• This topic is empty.
Viewing 1 post (of 1 total)
  • Author
    Posts
  • #5000

    The companies announced that the first participants have been dosed in the U.S. in the Phase 1/2 clinical trial for the BNT162 vaccine program to prevent COVID-19.

    Find out more.

Viewing 1 post (of 1 total)
  • You must be logged in to reply to this topic.